课题基金 / 基金详情

Wnt signaling-mediated control of blood-retinal barrier

Wnt signaling-mediated control of blood-retinal barrier
Wnt信号介导的血视网膜屏障控制
批准号:
9918370
负责人:
JING CHEN
金额:
$44.25万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-09-30 至 2022-04-30

项目摘要

项目成果

JING CHEN的其他基金

相似基金

相关文献

中文摘要
翻译
项目摘要 视网膜内皮细胞血-视网膜屏障(BRB)的破坏是视网膜水肿及其结果的主要原因 血管性眼病中的视力丧失。除了通过细胞间的紧密连接进行细胞外运输 内皮细胞(ECs),物质的运输,特别是大分子,也通过 跨内皮细胞的跨细胞小泡(跨细胞)。中枢神经系统中正常的健康血管, 包括视网膜在内,显示出维持血脑屏障(BBB)和内部的低比率的跨细胞反应。 BRB。然而,调控视网膜EC细胞转运的分子机制却知之甚少,这在很大程度上 限制了我们操纵内部BRB治疗血管性眼病的能力。在本项目中,我们确定了WNT 信号通路,一个对血管生成和血管完整性控制至关重要的通路,可能起作用 作为EC转胞作用的关键负性调节因子,以维持内部BRB。相互关联的Wnt基因的突变 涉及配体Norrin、受体Frizzled4和共受体低密度的信号通路 脂蛋白受体相关蛋白5(LRP5)与家族性渗出性玻璃体视网膜病变 (FEVR)和Norrie病,均伴有内皮细胞BRB破裂。规范Wnt信号的激活 包括稳定β-连环蛋白,然后将其移位到细胞核以结合核T细胞因子/淋巴系 增强因子(TCF/LEF)影响靶基因。我们的初步数据显示,WNT信号的丢失 FEVR和Norrie病小鼠模型(LRP5-/-和Norriny/-小鼠)显著增加EC的转细胞性, 随着MFSD2a(包含2a的主要促进剂超级家族结构域)水平的降低,一种膜 抑制EC转胞作用的转运蛋白。我们假设Wnt信号对于 通过Mfsd2a依赖的Mfsd2a维持视网膜EC的低转细胞率,这对BRB内部完整性至关重要 小窝囊泡调制。我们将通过三个目标来检验这一假设。在目标1中,我们将确定 WNT信号通过测量小分子和大分子的血管通透性来控制EC的细胞转运 在LRP5-/-和Norriny/-视网膜中,以及在EC培养中,使用带有Wnt调制的跨细胞试验。在AIM 2 我们将确定Wnt信号是否通过转录调控EC的转胞作用 MFSD2a,一种跨细胞抑制物,采用体外和体外相结合的方法。在《目标3》中,我们将 阐明Wnt信号和MFSD2a是否控制MFSD2a辅助的空泡形成, 运输和胞吐。这项拟议的工作将揭示新的基本分子机制 管理EC转胞和内部BRB的完整性,这对帮助发展改进的 操纵内部BRB的策略。这项工作的发现也将与血脑屏障的调制高度相关 在中枢神经系统中,以及通过血脑屏障和内血脑屏障给药方法的发展。
英文摘要
Project Summary Breakdown of the inner endothelial blood-retinal barrier (BRB) is a major cause of retinal edema and resultant vision loss in vascular eye diseases. In addition to paracellular transport though the tight junctions between endothelial cells (ECs), transportation of substance, particularly large molecules, also occurs through transcellular vesicles (transcytosis) across ECs. Normal healthy blood vessels in the central nervous system, including retinas, display low rates of transcytosis essential for maintaining blood-brain barrier (BBB) and inner BRB. Yet molecular mechanisms governing retinal EC transcytosis are poorly understood, which considerably limits our ability to manipulate inner BRB to treat vascular eye disease. In this project we identified that Wnt signaling pathway, a pathway fundamentally important for angiogenesis and vascular integrity control, may act as a critical negative regulator of EC transcytosis to maintain inner BRB. Mutations in the inter-related Wnt signaling pathway involving the ligand Norrin, and the receptor Frizzled4 and co-receptor low density lipoprotein receptor-related protein 5 (LRP5) are linked with development of familial exudative vitreoretinopathy (FEVR) and Norrie disease, both with inner endothelial BRB breakdown. Activation of canonical Wnt signaling involves stabilization of β-catenin, which then translocates to the nucleus to bind nuclear T-cell factor /lymphoid enhancer factor (TCF/LEF) to influence target genes. Our preliminary data show that loss of Wnt signaling in mouse models of FEVR and Norrie disease (Lrp5-/- and Norriny/- mice) significantly increased EC transcytosis, with decreased levels of MFSD2a (major facilitator super family domain containing 2a), a membrane transporter protein that suppresses EC transcytosis. We hypothesize that Wnt signaling is essential for maintaining a low transcytosis rate in retinal EC critical for inner BRB integrity, through Mfsd2a-dependent caveola vesicle modulation. We will test this hypothesis with three aims. In Aim 1 we will determine whether Wnt signaling controls EC transcytosis by measuring vascular permeability of both small and large molecules in Lrp5-/- and Norriny/- retinas, as well as in EC culture using transcytosis assay with Wnt modulation. In Aim 2 we will determine whether Wnt signaling regulates EC transcytosis through transcriptional regulation of MFSD2a, a transcytotic inhibitor, using a combination of ex vivo and in vitro approaches. In Aim 3, we will delineate whether Wnt signaling and MFSD2a control MFSD2a-assisted caveolar vesicle formation, transportation, and exocytosis. This proposed work will uncover novel fundamental molecular mechanisms governing EC transcytosis and inner BRB integrity, which is of significance in aiding development of improved strategies to manipulate inner BRB. Findings from this work will also be highly relevant for modulation of BBB in the central nervous system, as well as development of drug delivery methods through BBB and inner BRB.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Establishing A New Diagnostic Paradigm for Peripheral Artery Disease among Patients with Chronic Kidney Disease
  • 批准号:
    10465042
  • 项目类别:
  • 资助金额:
    $57.35万
  • 财政年份:
    2021
  • 负责人:
    JING CHEN
  • 依托单位:
Establishing A New Diagnostic Paradigm for Peripheral Artery Disease among Patients with Chronic Kidney Disease
  • 批准号:
    10677577
  • 项目类别:
  • 资助金额:
    $34.81万
  • 财政年份:
    2021
  • 负责人:
    JING CHEN
  • 依托单位:
Establishing A New Diagnostic Paradigm for Peripheral Artery Disease among Patients with Chronic Kidney Disease
  • 批准号:
    10186101
  • 项目类别:
  • 资助金额:
    $65.24万
  • 财政年份:
    2021
  • 负责人:
    JING CHEN
  • 依托单位:
Regulation of RPE degeneration by REV-ERBalpha
  • 批准号:
    10667553
  • 项目类别:
  • 资助金额:
    $53.32万
  • 财政年份:
    2020
  • 负责人:
    JING CHEN
  • 依托单位:
国内基金
海外基金
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
  • 批准号:
    32170319
  • 项目类别:
    面上项目
  • 资助金额:
    58.00万元
  • 批准年份:
    2021
  • 负责人:
    董春海
  • 依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
  • 批准号:
    --
  • 项目类别:
    --
  • 资助金额:
    58万元
  • 批准年份:
    2021
  • 负责人:
    董春海
  • 依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
  • 批准号:
    31372080
  • 项目类别:
    面上项目
  • 资助金额:
    80.0万元
  • 批准年份:
    2013
  • 负责人:
    杨迎伍
  • 依托单位: